Target intelligence / Profile preview

Human Extracellular Matrix Protein (ECM)

Target
ECM
Molecular classification
Structural protein, Glycoprotein, Proteoglycan
01

Overview

The human extracellular matrix (ECM) is a complex, dynamic, and non-cellular network of macromolecules that fills the space between cells in all tissues and organs. It provides essential physical scaffolding for cellular constituents and initiates crucial biochemical and biomechanical cues required for tissue morphogenesis, differentiation, homeostasis, repair, and disease processes. The ECM is primarily composed of structural proteins (mainly collagens), glycoproteins (e.g., fibronectin, laminin), and proteoglycans (core proteins with glycosaminoglycan side chains such as heparan sulfate, chondroitin sulfate, keratan sulfate). It provides structural support, regulates cell behavior, mediates cell adhesion, stores growth factors, facilitates communication, and enables dynamic remodeling. Different tissues have specialized ECMs reflecting their mechanical needs. Cells interact with the ECM via surface receptors, including integrins, DDRs, and syndecans. ECM undergoes constant remodeling involving synthesis/degradation cycles critical for normal physiology and pathological states. MMPs are key enzymes responsible for controlled breakdown of ECM components.

Other names
Extracellular matrixECM proteinsMatrix proteins
02

Mechanism of action

Varies depending on the specific component targeted; examples include inhibition of ECM degradation, blocking cell adhesion, and modulating growth factor signaling.

03

Biological functions

Structural supportCell adhesionCell signalingGrowth factor storageTissue repairCell migrationCell proliferationCell differentiationWound healingAngiogenesisMatricrine signaling
04

Disease associations

CancerFibrosisInflammationWound healingCardiovascular diseaseOsteoarthritis
05

Safety considerations

Off-target effects on other ECM componentsDisruption of tissue homeostasisUnintended consequences on cell behaviorPotential for promoting metastasis in certain cancer typesImmunogenicity
06

Interacting drugs

MMPs inhibitors

2 more in the full profile.

07

Biomarkers

ECM degradation productsCollagen fragmentsHyaluronic acidSpecific ECM protein levels in serum or tissue

Beyond the preview

Go deeper on Human Extracellular Matrix Protein (ECM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human Extracellular Matrix Protein (ECM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call